RATIONALE: At-home nocturnal pulse oximetry has a high positive predictive value (PPV) for polysomnographically-diagnosed obstructive sleep apnea (OSA) but no studies have been published testing the night-to-night consistency of at-home nocturnal pulse oximetry for the evaluation of suspected OSA in children. We therefore determined the night-to-night consistency of nocturnal pulse oximetry as a diagnostic test for OSA in children. METHODS: We prospectively studied 148 children (96 male) aged 4.9 ± 2.4 (1.2-11.8) years, referred for suspected OSA. To evaluate night-to-night consistency, we compared an oximetry analysis method, the McGill Oximetry Score (MOS), from two consecutive at-home nocturnal pulse oximetry recordings. RESULTS: Pulse oximetry metrics were similar on the two nights. The MOS on the two nights showed excellent night-to-night consistency when analyzed as positive for OSA versus inconclusive, 143/148 (Spearman's correlation coefficient = 0.90). A more detailed analysis using four categories (MOS 1, 2, 3, and 4) of OSA severity showed very good night-to-night agreement, 133/148 (Spearman's correlation coefficient = 0.91). Variability was increased in children younger than 4 years of age compared to older children. CONCLUSIONS: Night-to-night consistency of nocturnal pulse oximetry as a diagnostic test for OSA showed excellent agreement. Night-to-night consistency of pulse oximetry, as analyzed by the MOS, for diagnosis and severity evaluation further validates this abbreviated testing method for pediatric OSA. Polysomnography (PSG) is required to rule in or rule out OSA in children if a single night oximetry testing is inconclusive.
RATIONALE: At-home nocturnal pulse oximetry has a high positive predictive value (PPV) for polysomnographically-diagnosed obstructive sleep apnea (OSA) but no studies have been published testing the night-to-night consistency of at-home nocturnal pulse oximetry for the evaluation of suspected OSA in children. We therefore determined the night-to-night consistency of nocturnal pulse oximetry as a diagnostic test for OSA in children. METHODS: We prospectively studied 148 children (96 male) aged 4.9 ± 2.4 (1.2-11.8) years, referred for suspected OSA. To evaluate night-to-night consistency, we compared an oximetry analysis method, the McGill Oximetry Score (MOS), from two consecutive at-home nocturnal pulse oximetry recordings. RESULTS: Pulse oximetry metrics were similar on the two nights. The MOS on the two nights showed excellent night-to-night consistency when analyzed as positive for OSA versus inconclusive, 143/148 (Spearman's correlation coefficient = 0.90). A more detailed analysis using four categories (MOS 1, 2, 3, and 4) of OSA severity showed very good night-to-night agreement, 133/148 (Spearman's correlation coefficient = 0.91). Variability was increased in children younger than 4 years of age compared to older children. CONCLUSIONS: Night-to-night consistency of nocturnal pulse oximetry as a diagnostic test for OSA showed excellent agreement. Night-to-night consistency of pulse oximetry, as analyzed by the MOS, for diagnosis and severity evaluation further validates this abbreviated testing method for pediatric OSA. Polysomnography (PSG) is required to rule in or rule out OSA in children if a single night oximetry testing is inconclusive.
Authors: Roberto Hornero; Leila Kheirandish-Gozal; Gonzalo C Gutiérrez-Tobal; Mona F Philby; María Luz Alonso-Álvarez; Daniel Álvarez; Ehab A Dayyat; Zhifei Xu; Yu-Shu Huang; Maximiliano Tamae Kakazu; Albert M Li; Annelies Van Eyck; Pablo E Brockmann; Zarmina Ehsan; Narong Simakajornboon; Athanasios G Kaditis; Fernando Vaquerizo-Villar; Andrea Crespo Sedano; Oscar Sans Capdevila; Magnus von Lukowicz; Joaquín Terán-Santos; Félix Del Campo; Christian F Poets; Rosario Ferreira; Katalina Bertran; Yamei Zhang; John Schuen; Stijn Verhulst; David Gozal Journal: Am J Respir Crit Care Med Date: 2017-12-15 Impact factor: 21.405
Authors: Daniel Álvarez; María L Alonso-Álvarez; Gonzalo C Gutiérrez-Tobal; Andrea Crespo; Leila Kheirandish-Gozal; Roberto Hornero; David Gozal; Joaquín Terán-Santos; Félix Del Campo Journal: J Clin Sleep Med Date: 2017-05-15 Impact factor: 4.062